Loading...
Loading...
ForwardView Consulting downgraded
Joy Global Inc. JOY from Speculative Buy to Hold. The target price for Joy Global has been lowered from $21 to $13. Joy Global shares closed at $11.06 on Monday.
Analysts at Keefe Bruyette & Woods downgraded
Northstar Realty Finance CorpNRF from Outperform to Market Perform. The target price for NorthStar Realty Finance has been lowered from $23 to $13. NorthStar Realty Finance shares closed at $10.36 on Monday.
Analysts at Barclays downgraded
Brixmor Property Group IncBRX from Overweight to Equal-weight. The target price for Brixmor Property Group has been lowered from $28 to $25. Brixmor Property Group shares closed at $21.10 on Monday.
JP Morgan downgraded
BioCryst Pharmaceuticals, Inc. BCRX from Outperform to Neutral. The target price for Brixmor Property Group has been lowered to $5. Biocryst Pharmaceuticals shares closed at $1.78 on Monday.
Analysts at Canaccord Genuity downgraded
Quidel CorporationQDEL from Buy to Hold. The target price for Quidel has been lowered to $18. Quidel shares closed at $16.34 on Monday.
Analysts at Compass Point downgraded
Eagle Point Credit Company Inc ECC from Buy to Neutral. The target price for Eagle Point Credit Company has been lowered to $13. Eagle Point Credit Company shares closed at $14.23 on Monday.
Deutsche Bank downgraded
Loading...
Loading...
from Buy to Hold. Randgold Resources shares closed at $85.12 on Monday.
Jefferies downgraded
BioCryst Pharmaceuticals, Inc. BCRX from Buy to Hold. The target price for Biocryst Pharmaceuticals has been lowered from $14 to $2. Biocryst Pharmaceuticals shares closed at $1.78 on Monday.
Analysts at DA Davidson downgraded
Qualys Inc QLYS from Buy to Neutral. The target price for Qualys has been lowered from $51 to $25. Qualys shares closed at $22.51 on Monday.
Analysts at Kepler downgraded
UBS Group AG (USA) UBS from Buy to Hold. UBS shares closed at $14.76 on Monday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in